About This Webinar
This live and recorded web based CLE will offer attendees an overview of information sharing and how it can be a useful tool for companies to combat cyber threats. During this webinar, panelists will discuss the history and utility of various threat sharing organizations and tools. This is an opportunity to hear from industry leaders as they offer practical advice on how to use cyber threat sharing to effectively mitigate risk.
This course is brought to you by the Global Cyber Institute and Thomson Reuters and it is national accredited (get CLE in all 50 states).
Topics that will be discussed:
-
Overview of cyber threat sharing
-
The benefits and challeges of cyber threat sharing
-
Cybersecurity Information Sharing Act (CISA) Overview
-
Establishing Sharing Relationships
Who should attend?
- Lawyers
- Insurance executives
- In-house counsel
- Business executives
- Privacy attorneys
Speakers
- Daniel Garrie, Law & Forensics
- Michael Bonnano – Redgrave LLP
Attending the webinar
If you would like to attend the program, please click this link and add the program to your “Cart.” Please note you may need to click the link twice to reach the webinar’s page. To register for the program for free please use the following code: LNF100. When checking out please make sure that you only have this webinar in your cart, otherwise you may encounter problems when checking out. If you know someone who might be interested in this webinar, please forward this email to them.
About Law & Forensics
Law & Forensics is a strategic consulting firm with a global presence that assists clients with sensitive and complex electronic discovery, information governance, computer forensic, information security, and privacy issues. With a strong record for getting results, reducing costs, mitigating legal risks, and delivering value, Law & Forensics provides corporations, government agencies, law firms and other legal, business, and technology stakeholders with solutions to address complex litigations, sensitive investigations, and regulatory inquiries.